Moreover, based on data from the Human Protein Atlas, RNA expression is different in human prostate carcinoma samples: a majority are negative for GLP-1 receptors, and of the common human prostate cancer cell lines, only 22Rv1 and LNCaP cells express GLP-1 receptors at the RNA level [60]. This evidence concerns the gene GLP1R and prostate carcinoma.